伊之密(300415.SZ):半固態鎂合金注射成型機產品是專爲滿足新能汽車高性能、輕量化鎂合金鑄件而設計的智能裝備
格隆匯5月27日丨伊之密(300415.SZ)在投資者關係表示,公司半固態鎂合金注射成型機產品是專爲滿足新能汽車高性能、輕量化鎂合金鑄件而設計的智能裝備,產品採用了壓鑄和注塑工藝合二爲一的“一體化”成型方式,模具和成型材料與壓鑄工藝相似,工藝過程則接近於注塑成型。整機採用高速開合模技術、傳感測控、實時控制等先進技術,具有遠程監控、信息儲存與記憶、安全密匙及自動報警等功能,是集材料技術、自動控制技術、互聯網技術、液壓控制、機械設計爲一體的高端智能裝備,主要應用於生產新能源汽車用大型關鍵零部件,如新能源汽車的電機零件與中控儀表板橫樑等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.